Alexandra J. Lansky

Weston

Editor-in-Chief at Journal of the Society for Cardiovascular Angiography & Interventions

Featured in: Favicon

huffpost.com Favicon

drugs.com

thelancet.com Favicon

healio.com Favicon

hmpgloballearningnetwork.com Favicon

citoday.com Favicon

Articles

2025 Scientific Sessions

1 month ago | scai.confex.com | Alexandra J. Lansky |Suzanne J. Baron |Dean Kereiakes |Frank F. Ing

Welcome to the 2025 Scientific Sessions... please wait while the program loads. Oops! Your browser seems to have javascript disabled. Make sure javascript is enabled or try opening a different browser.
Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR: Results of a Patient-Level Pooled Analysis

May 5, 2024 | jacc.org | Alexandra J. Lansky |Daniel Grubman |Michael Dwyer |Robert Zivadinov

References1. "The problem with asymptomatic cerebral embolic complications in vascular procedures: what if they are not asymptomatic?"J Am Coll Cardiol . 2012;60:17: 1614-1616. 2. "Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis". Eur Heart J . 2019;40:38: 3143-3153. 3. "STS-ACC TVT registry of transcatheter aortic valve replacement". J Am Coll Cardiol . 2020;76:21: 2492-2516. 4.
Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.
Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.
2024 Scientific Sessions

Apr 9, 2024 | scai.confex.com | Alexandra J. Lansky |Suzanne J. Baron |Dean Kereiakes |Andrew Michael Goldsweig

Welcome to the 2024 Scientific Sessions...please wait while the program loads. Oops! Your browser seems to have javascript disabled. Make sure javascript is enabled or try opening a different browser.